PMC:7029759 / 25424-26887
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
615 | 33-37 | Gene | denotes | ACE2 | Gene:59272 |
616 | 90-94 | Gene | denotes | ACE2 | Gene:59272 |
617 | 396-400 | Gene | denotes | ACE2 | Gene:59272 |
618 | 422-426 | Gene | denotes | ACE2 | Gene:59272 |
619 | 539-543 | Gene | denotes | ACE2 | Gene:59272 |
620 | 615-629 | Gene | denotes | angiotensin II | Gene:183 |
621 | 724-728 | Gene | denotes | ACE2 | Gene:59272 |
622 | 888-892 | Gene | denotes | ACE2 | Gene:59272 |
623 | 1154-1160 | Gene | denotes | Ang1-8 | Gene:284 |
624 | 1397-1401 | Gene | denotes | ACE2 | Gene:59272 |
625 | 53-54 | Gene | denotes | S | Gene:43740568 |
626 | 43-52 | Species | denotes | 2019-nCoV | Tax:2697049 |
627 | 180-188 | Species | denotes | patients | Tax:9606 |
628 | 753-780 | Species | denotes | respiratory syncytial virus | Tax:12814 |
629 | 788-792 | Species | denotes | H5N1 | Tax:102793 |
630 | 882-887 | Species | denotes | human | Tax:9606 |
631 | 974-982 | Species | denotes | patients | Tax:9606 |
632 | 1444-1453 | Species | denotes | 2019-nCoV | Tax:2697049 |
633 | 1454-1462 | Species | denotes | patients | Tax:9606 |
634 | 793-802 | Species | denotes | influenza | Tax:11320 |
635 | 1220-1231 | Species | denotes | respiratory | Tax:12814 |
636 | 894-900 | Chemical | denotes | rhACE2 | |
637 | 1013-1019 | Chemical | denotes | rhACE2 | |
638 | 1277-1283 | Chemical | denotes | rhACE2 | |
639 | 140-149 | Disease | denotes | pneumonia | MESH:D011014 |
640 | 194-198 | Disease | denotes | SARS | MESH:D045169 |
641 | 203-222 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
642 | 231-240 | Disease | denotes | pneumonia | MESH:D011014 |
643 | 268-283 | Disease | denotes | pulmonary edema | MESH:D011654 |
644 | 288-323 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
645 | 325-329 | Disease | denotes | ARDS | MESH:D012128 |
646 | 369-373 | Disease | denotes | ARDS | MESH:D012128 |
647 | 584-595 | Disease | denotes | lung injury | MESH:D055370 |
648 | 745-749 | Disease | denotes | ARDS | MESH:D012128 |
649 | 806-815 | Disease | denotes | infection | MESH:D007239 |
650 | 951-955 | Disease | denotes | ARDS | MESH:D012128 |
651 | 959-973 | Disease | denotes | critically ill | MESH:D016638 |
652 | 1342-1346 | Disease | denotes | ARDS | MESH:D012128 |
653 | 1436-1440 | Disease | denotes | ARDS | MESH:D012128 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T569 | 382-387 | NCBITaxon:10239 | denotes | viral |
T568 | 396-400 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T567 | 422-426 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T566 | 445-455 | GO:0010467 | denotes | expression |
T565 | 487-496 | PG_1 | denotes | S protein |
T564 | 539-543 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T563 | 584-588 | UBERON:0002048 | denotes | lung |
T562 | 615-629 | PR:000036009;DG_37 | denotes | angiotensin II |
T561 | 676-690 | DG_37;PR:000001251 | denotes | angiotensin II |
T560 | 691-707 | PR:000001251 | denotes | type 1a receptor |
T559 | 724-728 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T558 | 753-764 | UBERON:0001004;NCBITaxon:12814 | denotes | respiratory |
T557 | 765-774 | NCBITaxon:12814 | denotes | syncytial |
T556 | 775-780 | NCBITaxon:10239 | denotes | virus |
T555 | 882-887 | SP_6;NCBITaxon:9606;PG_10 | denotes | human |
T554 | 888-892 | PG_10;PR:000003622 | denotes | ACE2 |
T553 | 1067-1088 | UBERON:0004535 | denotes | cardiovascular system |
T552 | 1154-1158 | PR:000004020 | denotes | Ang1 |
T551 | 1206-1216 | GO:0065007 | denotes | modulation |
T550 | 1220-1231 | UBERON:0001004 | denotes | respiratory |
T549 | 1370-1376 | NCBITaxon:33208 | denotes | animal |
T548 | 1397-1401 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T547 | 1444-1453 | SP_7 | denotes | 2019-nCoV |
T578 | 33-37 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T577 | 43-52 | SP_7 | denotes | 2019-nCoV |
T576 | 53-62 | PG_1 | denotes | S protein |
T575 | 90-94 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T574 | 194-198 | SP_10 | denotes | SARS |
T573 | 203-212 | SP_7 | denotes | 2019-nCoV |
T572 | 268-277 | UBERON:0002048 | denotes | pulmonary |
T571 | 294-305 | UBERON:0001004 | denotes | respiratory |
T570 | 341-348 | NCBITaxon:10239 | denotes | viruses |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T152 | 55-62 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T153 | 401-408 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T154 | 427-434 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T155 | 489-496 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T156 | 544-551 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T157 | 584-588 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T158 | 645-653 | Body_part | denotes | hormones | http://purl.org/sig/ont/fma/fma12278 |
T159 | 1067-1088 | Body_part | denotes | cardiovascular system | http://purl.org/sig/ont/fma/fma7161 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T17 | 584-588 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T18 | 1067-1088 | Body_part | denotes | cardiovascular system | http://purl.obolibrary.org/obo/UBERON_0004535 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p4551s19 | 435-444 | NegReg | denotes | decreased |
p4551s20 | 445-455 | MPA | denotes | expression |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T81 | 140-149 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T82 | 194-198 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T83 | 203-222 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
T84 | 213-222 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T85 | 231-240 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T86 | 268-283 | Disease | denotes | pulmonary edema | http://purl.obolibrary.org/obo/MONDO_0006932 |
T87 | 288-323 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T88 | 294-323 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T89 | 325-329 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T90 | 369-373 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T91 | 578-595 | Disease | denotes | acute lung injury | http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796 |
T93 | 589-595 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T94 | 745-749 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T95 | 793-802 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T96 | 806-815 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T97 | 951-955 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T98 | 1342-1346 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T99 | 1436-1440 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T232 | 41-42 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T233 | 167-168 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T234 | 341-348 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T235 | 552-555 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T236 | 584-588 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T237 | 584-588 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T238 | 775-780 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T239 | 882-887 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T240 | 984-985 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T241 | 1067-1088 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | cardiovascular system |
T242 | 1067-1088 | http://www.ebi.ac.uk/efo/EFO_0000791 | denotes | cardiovascular system |
T243 | 1093-1094 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T244 | 1161-1168 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T245 | 1299-1302 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T246 | 1370-1376 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T247 | 1402-1404 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T92 | 55-62 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T93 | 401-408 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T94 | 427-434 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T95 | 489-496 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T96 | 544-551 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T97 | 615-629 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T100 | 615-626 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T101 | 627-629 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T102 | 645-653 | Chemical | denotes | hormones | http://purl.obolibrary.org/obo/CHEBI_24621 |
T103 | 676-690 | Chemical | denotes | angiotensin II | http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506 |
T106 | 676-687 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T107 | 688-690 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T108 | 1101-1103 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T109 | 1161-1168 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T163 | 0-166 | Sentence | denotes | An additional advantage of using ACE2 as a 2019-nCoV S protein neutralizing agent is that ACE2 administration could also directly treat the pneumonia pathophysiology. |
T164 | 167-336 | Sentence | denotes | A portion of patients with SARS and 2019-nCoV infection develop pneumonia, which is characterized by pulmonary edema and acute respiratory distress syndrome (ARDS) 1, 2. |
T165 | 337-508 | Sentence | denotes | The viruses may, in part, cause ARDS through viral-induced ACE2 protein shedding and ACE2 protein decreased expression, both of which are mediated by S protein binding 54. |
T166 | 509-711 | Sentence | denotes | Administration of recombinant ACE2 protein has been shown to improve acute lung injury through decreasing angiotensin II levels and the hormones subsequent binding to angiotensin II type 1a receptor 57. |
T167 | 712-823 | Sentence | denotes | Recombinant ACE2 can also reduce ARDS in respiratory syncytial virus 58 and H5N1 influenza 59 infection models. |
T168 | 824-983 | Sentence | denotes | Based on these promising preclinical studies, recombinant human ACE2 (rhACE2) was moved into clinical trials in order to treat ARDS in critically ill patients. |
T169 | 984-1092 | Sentence | denotes | A phase I trial demonstrated rhACE2 was well tolerated with no effects seen on the cardiovascular system 60. |
T170 | 1093-1246 | Sentence | denotes | A phase II trial demonstrated on-target efficacy in reducing Ang1-8 peptide levels, but did not show significant modulation of respiratory parameters 61. |
T171 | 1247-1463 | Sentence | denotes | It remains to be seen whether rhACE2 administration has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T14 | 140-149 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T15 | 231-240 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T16 | 268-283 | Phenotype | denotes | pulmonary edema | http://purl.obolibrary.org/obo/HP_0100598 |
T17 | 294-314 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T18 | 578-595 | Phenotype | denotes | acute lung injury | http://www.orpha.net/ORDO/Orphanet_178320 |